Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2877)
All Articles published online
|
Jul 28, 2006 (publication date) through Apr 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nakao A, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Kodera Y, Inoue S, Takeda S. Oncological problems in pancreatic cancer surgery. World J Gastroenterol 2006; 12(28): 4466-4472 [PMID: 16874856 DOI: 10.3748/wjg.v12.i28.4466] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i28/4466.htm |
| Number | Citing Articles |
| 1 |
Ashleigh Hull, William Hsieh, Artem Borysenko, William Tieu, Dylan Bartholomeusz, Eva Bezak. Development of [225Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibration. EJNMMI Radiopharmacy and Chemistry 2023; 8(1) doi: 10.1186/s41181-023-00209-z
|
| 2 |
Chika Igarashi, Yukie Yoshii, Hideaki Tashima, Yuma Iwao, Kohei Sakurai, Fukiko Hihara, Tomoko Tachibana, Eiji Yoshida, Hidekatsu Wakizaka, Go Akamatsu, Taiga Yamaya, Mitsuyoshi Yoshimoto, Hiroki Matsumoto, Ming-Rong Zhang, Kotaro Nagatsu, Aya Sugyo, Atsushi B. Tsuji, Tatsuya Higashi. Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xenograft mouse model of resectable pancreatic cancer. Nuclear Medicine Communications 2021; 42(10): 1112 doi: 10.1097/MNM.0000000000001442
|
| 3 |
Anu Autio, Tiina Ujula, Pauliina Luoto, Satu Salomäki, Sirpa Jalkanen, Anne Roivainen. PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG. European Journal of Nuclear Medicine and Molecular Imaging 2010; 37(10): 1918 doi: 10.1007/s00259-010-1497-y
|
| 4 |
Yukie Yoshii, Hiroki Matsumoto, Mitsuyoshi Yoshimoto, Yoko Oe, Ming-Rong Zhang, Kotaro Nagatsu, Aya Sugyo, Atsushi B. Tsuji, Tatsuya Higashi. 64Cu-Intraperitoneal Radioimmunotherapy: A Novel Approach for Adjuvant Treatment in a Clinically Relevant Preclinical Model of Pancreatic Cancer. Journal of Nuclear Medicine 2019; 60(10): 1437 doi: 10.2967/jnumed.118.225045
|
| 5 |
William McGahan, Venkata Chikatamarla, Paul Thomas, David Cavallucci, Nicholas O'Rourke, Matthew Burge. High SUVmax on routine pre-operative FDG-PET predicts early recurrence in pancreatic and peri-ampullary cancer. HPB 2022; 24(8): 1387 doi: 10.1016/j.hpb.2022.01.005
|
| 6 |
Yangchao Chen, Dan Xie, Wing Yin Li, Chi Man Cheung, Hong Yao, Ching Yu Chan, Chu-yan Chan, Fang-Ping Xu, Yan-Hui Liu, Joseph J.Y. Sung, Hsiang-fu Kung. RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo. Cancer Letters 2010; 297(1): 109 doi: 10.1016/j.canlet.2010.05.003
|
| 7 |
Kazuo Yamamura, Akimasa Nakao, Tsutomu Fujii, Suguru Yamada, Hiroyuki Sugimoto, Hideki Kasuya, Shuji Nomoto, Yasuhiro Kodera, Shigeo Nakamura, Satoshi Morita, Shin Takeda. Clinicopathologic Study of Intrapancreatic Cancer Spread in Carcinoma of the Body and Tail of the Pancreas. Pancreas 2012; 41(5): 753 doi: 10.1097/MPA.0b013e31823b12a4
|
| 8 |
Xu‐Feng Zhang, Eliza W. Beal, Jeffery Chakedis, Qinyu Chen, Yi Lv, Cecilia G. Ethun, Ahmed Salem, Sharon M. Weber, Thuy Tran, George Poultsides, Andre Y. Son, Ioannis Hatzaras, Linda Jin, Ryan C. Fields, Stefan Buettner, Charles Scoggins, Robert C. G. Martin, Chelsea A. Isom, Kamron Idrees, Harveshp D. Mogal, Perry Shen, Shishir K. Maithel, Carl R. Schmidt, Timothy M. Pawlik. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative‐intent Surgery: A Multi‐institutional Study from the US Extrahepatic Biliary Malignancy Consortium. World Journal of Surgery 2018; 42(9): 2919 doi: 10.1007/s00268-018-4530-0
|
| 9 |
Fukiko Hihara, Hiroki Matsumoto, Mitsuyoshi Yoshimoto, Takashi Masuko, Yuichi Endo, Chika Igarashi, Tomoko Tachibana, Mitsuhiro Shinada, Ming-Rong Zhang, Gene Kurosawa, Aya Sugyo, Atsushi B. Tsuji, Tatsuya Higashi, Hiroaki Kurihara, Makoto Ueno, Yukie Yoshii. In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study. International Journal of Molecular Sciences 2022; 23(10): 5807 doi: 10.3390/ijms23105807
|
| 10 |
John J. Grzesiak, Michael Bouvet. Divalent cations modulate the integrin‐mediated malignant phenotype in pancreatic cancer cells. Cancer Science 2008; 99(8): 1553 doi: 10.1111/j.1349-7006.2008.00855.x
|
| 11 |
Yu Mou, Yi Song, Jinheng Liu, Haiyu Song, Xubao Liu, Jiang Li, Nengwen Ke. Long Term Outcomes of No-Touch Isolation Principles Applied in Pancreaticoduodenectomy for Treatment of Pancreatic Adenocarcinoma: A Multicenter Retrospective Study with Propensity Score Matching. Journal of Clinical Medicine 2023; 12(2): 632 doi: 10.3390/jcm12020632
|
| 12 |
M Kanda, T Fujii, Y Kodera, S Nagai, S Takeda, A Nakao. Nutritional predictors of postoperative outcome in pancreatic cancer. British Journal of Surgery 2010; 98(2): 268 doi: 10.1002/bjs.7305
|
| 13 |
Oliver Drognitz, Karl Henne, Christian Weissenberger, Gregor Bruggmoser, Heike Göbel, Ulrich Theodor Hopt, Herrmann Frommhold, Günther Ruf. Long-Term Results After Intraoperative Radiation Therapy for Gastric Cancer. International Journal of Radiation Oncology*Biology*Physics 2008; 70(3): 715 doi: 10.1016/j.ijrobp.2007.07.2331
|
| 14 |
Mitsuro Kanda, Tsutomu Fujii, Shunji Nagai, Yasuhiro Kodera, Akiyuki Kanzaki, Tevfik T. Sahin, Masamichi Hayashi, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao. Pattern of Lymph Node Metastasis Spread in Pancreatic Cancer. Pancreas 2011; 40(6): 951 doi: 10.1097/MPA.0b013e3182148342
|
| 15 |
Shunsuke Onoe, Yuji Kaneoka, Atsuyuki Maeda, Yuichi Takayama, Yasuyuki Fukami. Preoperative radiographic vascular involvement score predicts the prognosis of resected pancreatic head adenocarcinoma. Langenbeck's Archives of Surgery 2017; 402(3): 439 doi: 10.1007/s00423-017-1562-0
|
| 16 |
Toru Aoyama, Yohei Miyagi, Masaaki Murakawa, Koichiro Yamaoku, Yosuke Atsumi, Manabu Shiozawa, Makoto Ueno, Manabu Morimoto, Takashi Oshima, Norio Yukawa, Takaki Yoshikawa, Yasushi Rino, Munetaka Masuda, Soichiro Morinaga. Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine. Oncology Letters 2017; 13(5): 3423 doi: 10.3892/ol.2017.5935
|
| 17 |
Vijay Kumar, Dilip K. Boddeti. Theranostics, Gallium-68, and Other Radionuclides. Recent Results in Cancer Research 2013; 194: 189 doi: 10.1007/978-3-642-27994-2_11
|
| 18 |
Tamotsu Kuroki, Susumu Eguchi. No-touch isolation techniques for pancreatic cancer. Surgery Today 2017; 47(1): 8 doi: 10.1007/s00595-016-1317-5
|
| 19 |
Yoshifumi Iwagami, Hidetoshi Eguchi, Hiroshi Wada, Yoshito Tomimaru, Naoki Hama, Koichi Kawamoto, Shogo Kobayashi, Masaki Mori, Yuichiro Doki, Hiroaki Nagano. Implications of peritoneal lavage cytology in resectable left-sided pancreatic cancer. Surgery Today 2015; 45(4): 444 doi: 10.1007/s00595-014-0964-7
|
| 20 |
Suguru Yamada, Shin Takeda, Tsutomu Fujii, Shuji Nomoto, Naohito Kanazumi, Hiroyuki Sugimoto, Hideki Kasuya, Yasuhiro Kodera, Tetsuro Nagasaka, Satoshi Morita, Akimasa Nakao. Clinical Implications of Peritoneal Cytology in Potentially Resectable Pancreatic Cancer. Annals of Surgery 2007; 246(2): 254 doi: 10.1097/01.sla.0000261596.43439.92
|
| 21 |
Takehiro Okabayashi, Kazuhiro Hanazaki. Surgical outcome of adenosquamous carcinoma of the pancreas. World Journal of Gastroenterology 2008; 14(44): 6765-6770 doi: 10.3748/wjg.14.6765
|
| 22 |
J-Matthias Löhr. Medical treatment of pancreatic cancer. Expert Review of Anticancer Therapy 2007; 7(4): 533 doi: 10.1586/14737140.7.4.533
|
| 23 |
Eiji Uchida, Matsuo Inoue, Takayuki Aimoto, Yoshiharu Nakamura, Akira Katsuno, Takashi Tajiri. Preventing Liver Metastasis by Resecting the Primary Pancreatic Carcinoma at an Early Stage of Intrapancreatic Transplantation in Hamsters. Journal of Nippon Medical School 2007; 74(1): 37 doi: 10.1272/jnms.74.37
|
| 24 |
Hisashi Hara, Tsuyoshi Takahashi, Rie Nakatsuka, Shigeyoshi Higashi, Tetsuji Naka, Kazuki Sumiyama, Yasuhiro Miyazaki, Tomoki Makino, Yukinori Kurokawa, Makoto Yamasaki, Shuji Takiguchi, Masaki Mori, Yuichiro Doki, Kiyokazu Nakajima. A novel approach of optical biopsy using probe-based confocal laser endomicroscopy for peritoneal metastasis. Surgical Endoscopy 2016; 30(8): 3437 doi: 10.1007/s00464-015-4626-7
|
| 25 |
Jana Kaťuchová, Juray Bober, Jozef Radoňak. Postoperative complications and survival rates for pancreatic cancer patients. Wiener klinische Wochenschrift 2011; 123(3-4): 94 doi: 10.1007/s00508-010-1513-z
|
| 26 |
Mina Waraya, Keishi Yamashita, Hiroyuki Katagiri, Kenichiro Ishii, Yoshihito Takahashi, Kazunori Furuta, Masahiko Watanabe. Preoperative Serum CA19-9 and Dissected Peripancreatic Tissue Margin as Determiners of Long-Term Survival in Pancreatic Cancer. Annals of Surgical Oncology 2009; 16(5): 1231 doi: 10.1245/s10434-009-0415-7
|
| 27 |
Hongkui Jin, Renhui Yang, Zhong Zheng, Mally Romero, Jed Ross, Hani Bou-Reslan, Richard A.D. Carano, Ian Kasman, Elaine Mai, Judy Young, Jiping Zha, Zemin Zhang, Sarajane Ross, Ralph Schwall, Gail Colbern, Mark Merchant. MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival. Cancer Research 2008; 68(11): 4360 doi: 10.1158/0008-5472.CAN-07-5960
|
| 28 |
Stephen A. Mihalcik, Sophia Virani, Theodore S. Hong, Andrzej Niemierko, Mari Mino-Kenudson, Wendy K. Kobayashi, Carlos Fernández-del Castillo, Harvey J. Mamon. Assessment of the Utility of Laparoscopy and Peritoneal Cytology in the Staging of Pancreatic Cancer. Pancreas 2017; 46(7): e60 doi: 10.1097/MPA.0000000000000866
|
| 29 |
Akihito Machinaga, Yuichi Hori, Kazuya Shimizu, Kyohei Okahara, Emmy Yanagita, Makoto Miyoshi, Tomoo Itoh, Ken Sasai. Xenografts Derived From Patients' Ascites Recapitulate the Gemcitabine Resistance Observed in Pancreatic Cancer Patients. Pancreas 2019; 48(10): 1294 doi: 10.1097/MPA.0000000000001438
|
| 30 |
Tsutomu Fujii. Extended Lymphadenectomy in Pancreatic Cancer Is Crucial. World Journal of Surgery 2013; 37(8): 1778 doi: 10.1007/s00268-013-2039-0
|
| 31 |
Eiji Uchida, Akira Matsushita, Ken Yanagi, Makoto Hiroi, Takayuki Aimoto, Yoshiharu Nakamura, Tadashi Yokoyama, Takashi Tajiri. Experimental Pancreatic Cancer Model Using PGHAM-1 Cells: Characteristics and Experimental Therapeutic Trials. Journal of Nippon Medical School 2008; 75(6): 325 doi: 10.1272/jnms.75.325
|
| 32 |
John J. Grzesiak, Fabian Vargas, Michael Bouvet. Divalent Cations Modulate α2β1 Integrin-Mediated Malignancy in a Novel 3-Dimensional In Vitro Model of Pancreatic Cancer. Pancreas 2010; 39(6): 904 doi: 10.1097/MPA.0b013e3181ce60a3
|
| 33 |
Mitsuro Kanda, Tsutomu Fujii, Tevfik T. Sahin, Akiyuki Kanzaki, Shunji Nagai, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Yasuhiro Kodera, Satoshi Morita, Akimasa Nakao. Invasion of the Splenic Artery Is a Crucial Prognostic Factor in Carcinoma of the Body and Tail of the Pancreas. Annals of Surgery 2010; 251(3): 483 doi: 10.1097/SLA.0b013e3181cf9171
|
| 34 |
John J. Grzesiak, Michael Bouvet. Activation of the α2β1 integrin‐mediated malignant phenotype on type I collagen in pancreatic cancer cells by shifts in the concentrations of extracellular Mg2+ and Ca2+. International Journal of Cancer 2008; 122(10): 2199 doi: 10.1002/ijc.23368
|
| 35 |
Tiina Ujula, Satu Salomäki, Anu Autio, Pauliina Luoto, Tuula Tolvanen, Pertti Lehikoinen, Tapio Viljanen, Hannu Sipilä, Pirkko Härkönen, Anne Roivainen. 68Ga-Chloride PET Reveals Human Pancreatic Adenocarcinoma Xenografts in Rats—Comparison with FDG. Molecular Imaging and Biology 2010; 12(3): 259 doi: 10.1007/s11307-009-0267-3
|
| 36 |
Marianna Borecka, Petra Zemankova, Filip Lhota, Jana Soukupova, Petra Kleiblova, Michal Vocka, Pavel Soucek, Ivana Ticha, Zdenek Kleibl, Marketa Janatova. The c.657del5 variant in the NBN gene predisposes to pancreatic cancer. Gene 2016; 587(2): 169 doi: 10.1016/j.gene.2016.04.056
|
| 37 |
Toru Aoyama, Keisuke Kazama, Yohei Miyagi, Masaaki Murakawa, Koichiro Yamaoku, Yosuke Atsumi, Manabu Shiozawa, Makoto Ueno, Manabu Morimoto, Takashi Oshima, Norio Yukawa, Takaki Yoshikawa, Yasushi Rino, Munetaka Masuda, Soichiro Morinaga. Predictive role of human equilibrative nucleoside transporter 1 in patients with pancreatic cancer treated by curative resection and gemcitabine-only adjuvant chemotherapy. Oncology Letters 2017; 14(1): 599 doi: 10.3892/ol.2017.6220
|
| 38 |
Christian M. Ellis, Sadashiv Shenoy, Alan Litwin, Stephanie Soehnlein, John F. Gibbs. Effective Endovascular Stenting of Malignant Portal Vein Obstruction in Pancreatic Cancer. HPB Surgery 2009; 2009: 1 doi: 10.1155/2009/426436
|
| 39 |
Jennifer Taylor, Jonathan Hickson, Tamara Lotan, Diane Seiko Yamada, Carrie Rinker-Schaeffer. Using metastasis suppressor proteins to dissect interactions among cancer cells and their microenvironment. Cancer and Metastasis Reviews 2008; 27(1): 67 doi: 10.1007/s10555-007-9106-7
|
| 40 |
Jeannine Bachmann, Mathias Heiligensetzer, Holger Krakowski-Roosen, Markus W. Büchler, Helmut Friess, Marc E. Martignoni. Cachexia Worsens Prognosis in Patients with Resectable Pancreatic Cancer. Journal of Gastrointestinal Surgery 2008; 12(7): 1193 doi: 10.1007/s11605-008-0505-z
|
| 41 |
Ioannis Pozios, Thomas Knösel, Yue Zhao, Gerald Assmann, Iraklis Pozios, Mario H. Müller, Christiane J. Bruns, Martin E. Kreis, Hendrik Seeliger. Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma. Journal of Cancer Research and Clinical Oncology 2018; 144(10): 1887 doi: 10.1007/s00432-018-2717-2
|
| 42 |
Eiji UCHIDA, Akira MATSUSHITA, Ken YANAGI, Makoto HIROI, Takayuki AIMOTO, Yoshiharu NAKAMURA, Munehisa FUKUHARA, Tadashi YOKOYAMA, Takashi TAJIRI. Hamster pancreatic cancer model for research on metastasis and therapeutic trials. Suizo 2008; 23(1): 60 doi: 10.2958/suizo.23.60
|
| 43 |
Ryuji Yoshioka, Akio Saiura, Rintaro Koga, Junichi Arita, Nobuyuki Takemura, Yoshihiro Ono, Junji Yamamoto, Toshiharu Yamaguchi. The Implications of Positive Peritoneal Lavage Cytology in Potentially Resectable Pancreatic Cancer. World Journal of Surgery 2012; 36(9): 2187 doi: 10.1007/s00268-012-1622-0
|
| 44 |
Genevieve M. Boland, Sarah P. Thayer. Pancreatic Cancer. 2008; : 181 doi: 10.1007/978-0-387-69252-4_11
|
| 45 |
Koichi Kato, Suguru Yamada, Hiroyuki Sugimoto, Naohito Kanazumi, Shuji Nomoto, Shin Takeda, Yasuhiro Kodera, Satoshi Morita, Akimasa Nakao. Prognostic Factors for Survival After Extended Pancreatectomy for Pancreatic Head Cancer. Pancreas 2009; 38(6): 605 doi: 10.1097/MPA.0b013e3181a4891d
|
| 46 |
Chunlin Ge, Ning Ma, Dianbo Yao, Fengming Luan, Chaojun Hu, Yongzhe Li, Yongfeng Liu. A serum Biomarker model to diagnose pancreatic cancer using proteomic fingerprint technology. Chinese Journal of Clinical Oncology 2008; 5(3): 200 doi: 10.1007/s11805-008-0200-6
|
| 47 |
Fuyuhiko Motoi, Toshiki Rikiyama, Yu Katayose, Shin-ichi Egawa, Michiaki Unno. Retrospective Evaluation of the Influence of Postoperative Tumor Marker Status on Survival and Patterns of Recurrence After Surgery for Pancreatic Cancer Based on RECIST Guidelines. Annals of Surgical Oncology 2011; 18(2): 371 doi: 10.1245/s10434-010-1311-x
|
| 48 |
Mitsuro Kanda, Shin Takeda, Suguru Yamada, Tsutomu Fujii, Hiroyuki Sugimoto, Naohito Kanazumi, Shuji Nomoto, Akimasa Nakao. Operative Treatment of Thrombotic Occlusion of the Portal Vein Immediately After Pancreatectomy With Portal Vein Resection. Pancreas 2010; 39(2): 265 doi: 10.1097/MPA.0b013e3181baef66
|
| 49 |
Shuichi Aoki, Fuyuhiko Motoi, Yoshiaki Murakami, Masayuki Sho, Sohei Satoi, Goro Honda, Kenichiro Uemura, Ken-ichi Okada, Ippei Matsumoto, Minako Nagai, Hiroaki Yanagimoto, Masanao Kurata, Takumi Fukumoto, Masamichi Mizuma, Hiroki Yamaue, Michiaki Unno. Decreased serum carbohydrate antigen 19–9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5460-4
|